These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 17826769)

  • 21. Promoter hypermethylation of the PALB2 susceptibility gene in inherited and sporadic breast and ovarian cancer.
    Potapova A; Hoffman AM; Godwin AK; Al-Saleem T; Cairns P
    Cancer Res; 2008 Feb; 68(4):998-1002. PubMed ID: 18281473
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Large BRCA1 and BRCA2 genomic rearrangements in Danish high risk breast-ovarian cancer families.
    Hansen Tv; Jønson L; Albrechtsen A; Andersen MK; Ejlertsen B; Nielsen FC
    Breast Cancer Res Treat; 2009 May; 115(2):315-23. PubMed ID: 18546071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of a novel BRCA1 large genomic rearrangement in a Spanish breast/ovarian cancer family.
    Palanca Suela S; Esteban Cardeñosa E; Barragán González E; Oltra Soler S; de Juan Jiménez I; Chirivella González I; Segura Huerta A; Guillén Ponce C; Martínez de Dueñas E; Bolufer Gilabert P;
    Breast Cancer Res Treat; 2008 Nov; 112(1):63-7. PubMed ID: 18060491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulatory aspects of genetic research with residual human tissue: effective and efficient data coding.
    Schmidt MK; Vermeulen E; Tollenaar RA; Van't Veer LJ; van Leeuwen FE
    Eur J Cancer; 2009 Sep; 45(13):2376-82. PubMed ID: 19362816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The expanding role of genetics in contraception and women's health.
    Shulman LP; Shields W
    Contraception; 2005 Feb; 71(2):81-3. PubMed ID: 15707554
    [No Abstract]   [Full Text] [Related]  

  • 26. Prediction of BRCA1-association in hereditary non-BRCA1/2 breast carcinomas with array-CGH.
    Joosse SA; van Beers EH; Tielen IH; Horlings H; Peterse JL; Hoogerbrugge N; Ligtenberg MJ; Wessels LF; Axwijk P; Verhoef S; Hogervorst FB; Nederlof PM
    Breast Cancer Res Treat; 2009 Aug; 116(3):479-89. PubMed ID: 18704682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Breast cancer susceptibility genes.
    Calzone KA
    Nurs Spectr (Wash D C); 1998 Nov; 8(22):12-4; quiz 14. PubMed ID: 10542765
    [No Abstract]   [Full Text] [Related]  

  • 28. Identification of BRCA1-IRIS, a BRCA1 locus product.
    ElShamy WM; Livingston DM
    Nat Cell Biol; 2004 Oct; 6(10):954-67. PubMed ID: 15448696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Homonucleotide tracts, short repeats and CpG/CpNpG motifs are frequent sites for heterogeneous mutations in the neurofibromatosis type 1 (NF1) tumour-suppressor gene.
    Rodenhiser DI; Andrews JD; Mancini DN; Jung JH; Singh SM
    Mutat Res; 1997 Feb; 373(2):185-95. PubMed ID: 9042399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparability versus statistical correctness.
    Mann RM; Span PN; Hoogerbrugge N
    Eur J Radiol; 2013 Dec; 82(12):e908. PubMed ID: 24054543
    [No Abstract]   [Full Text] [Related]  

  • 31. Good correlation does not automatically imply good agreement: the trouble with comparing tumour size by breast MRI versus histopathology.
    Lobbes MB; Nelemans PJ
    Eur J Radiol; 2013 Dec; 82(12):e906-7. PubMed ID: 24016826
    [No Abstract]   [Full Text] [Related]  

  • 32. Transposon-derived repeats in the human genome and 5-methylcytosine-associated mutations in adjacent genes.
    Bjornsson HT; Ellingsen LM; Jonsson JJ
    Gene; 2006 Mar; 370():43-50. PubMed ID: 16446059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Production of knockout rats using ENU mutagenesis and a yeast-based screening assay.
    Zan Y; Haag JD; Chen KS; Shepel LA; Wigington D; Wang YR; Hu R; Lopez-Guajardo CC; Brose HL; Porter KI; Leonard RA; Hitt AA; Schommer SL; Elegbede AF; Gould MN
    Nat Biotechnol; 2003 Jun; 21(6):645-51. PubMed ID: 12754522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene knockout experiments to quantify a G2/M genetic network simulation for mammary cancer susceptibility.
    Bankhead A; Magnuson NS; Heckendorn RB
    In Silico Biol; 2006; 6(3):181-92. PubMed ID: 16922682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tandem repeats in protein coding regions of primate genes.
    Borstnik B; Pumpernik D
    Genome Res; 2002 Jun; 12(6):909-15. PubMed ID: 12045144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting mammalian genes--rats join in and mice move ahead.
    Rossant J
    Nat Biotechnol; 2003 Jun; 21(6):625-7. PubMed ID: 12776146
    [No Abstract]   [Full Text] [Related]  

  • 37. Mutational hotspots in the TP53 gene and, possibly, other tumor suppressors evolve by positive selection.
    Glazko GV; Babenko VN; Koonin EV; Rogozin IB
    Biol Direct; 2006 Jan; 1():4. PubMed ID: 16542006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CpG + CpNpG analysis of protein-coding sequences from tomato.
    Hobolth A; Nielsen R; Wang Y; Wu F; Tanksley SD
    Mol Biol Evol; 2006 Jun; 23(6):1318-23. PubMed ID: 16600999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. No evidence for coding region mutations in the retinoblastoma-associated Kruppel-associated box protein gene (RBaK) causing familial hyperaldosteronism type II.
    So A; Jeske YW; Gordon RD; Duffy D; Kelemen L; Stowasser M
    Clin Endocrinol (Oxf); 2006 Dec; 65(6):829-31. PubMed ID: 17121540
    [No Abstract]   [Full Text] [Related]  

  • 40. The implications of de novo coding mutations in simplex autism families.
    Utami KH
    Clin Genet; 2015 May; 87(5):428-9. PubMed ID: 25753786
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.